Spanish White Biotech Pipeline

VIVEBIOTECH

Development of more cost-effective gene therapy processes

Indication: Optimization of manufacturing, automation, scale-up strategies, vector engineering and regulatory harmonization, among others, to reduce the costs associated with gene therapy.

Phase: 4Basic R&D 4Applied R&D

Status of explotiation: 4Available